To assess the clinical relevance of our findings, we analyzed the expression levels of RORα, Bnip3, and PGC-1α in the livers of patients with steatohepatitis, including NASH, using publicly available databases (GSE33814 and GSE48452)27,28. Here, BNIP3 is linked to metabolic dysfunction-associated steatohepatitis.